Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9578 posts found.

teva_copy

Teva loses patent protection on lucrative MS treatment

August 25, 2016 Manufacturing and Production, Research and Development, Sales and Marketing Copaxone, Mylan, Teva, multiple sclerosis

Teva’s stock plunged 3% after a US agency ruled that two of its patents related to multiple sclerosis drug Copaxone …
News
amgen_flag

FDA says no to Amgen’s Parsabiv

August 25, 2016 Research and Development, Sales and Marketing Amgen, FDA, par

Amgen has announced that the US Food and Drug Administration (FDA) has issued a complete response letter rejecting Parsabiv (etelcalcetide) …
News
fdaoutsideweb

Medical device user fees to increase 68% for 2018 to 2022

August 25, 2016 Research and Development, Sales and Marketing FDA, Medical device

The Food and Drug Administration has reached an agreement with the medical device industry and laboratory community on proposed recommendations …
News
mylan_plus_hero_720x510

Mylan latest target of US anger on drug pricing with EpiPen price increase

August 24, 2016 Research and Development, Sales and Marketing Mylan, US, congress, controversy, epipen, price gouging, price increase

The US congress is again subjecting the pharmaceutical industry to heavy scrutiny over drug pricing policies with Mylan its latest …
News

NICE approves lung cancer and leukaemia treatments

August 24, 2016 Research and Development, Sales and Marketing Alimta, CDF, NICE, bosulif, bosutinib, pemetrexed

The National Institute for Health and Care Excellence (NICE) has issued its approval of two drugs for routine use on …
News
pfizer_sky

Pfizer to acquire AstraZeneca’s anti-infective business for $550 million upfront

August 24, 2016 Research and Development, Sales and Marketing AstraZeneca, Pfizer, Zavicefta, anti-infective

Pfizer has announced that it is to acquire AstraZeneca’s small molecule anti-infective business in a deal potentially worth up to …
News
eylea-product-box-md

NICE recommends Eylea as first-line treatment for sight threatening condition

August 24, 2016 Research and Development, Sales and Marketing Bayer, Eylea, NHS, NICE, first-line treatment

Bayer has announced that the National Institute for Health and Care Excellence (NICE) has recommended Eylea (aflibercept) as a cost-effective …
News
1397501171305

AbbVie’s leukaemia drug granted positive opinion by MHRA through EAMS

August 23, 2016 Research and Development, Sales and Marketing

AbbVie’s investigational treatment for chronic lymphocytic leukaemia (CLL) venetoclax has been granted a positive scientific opinion by the Medicines and …
News
t_cell_grey_killing_tumour_cell_yellow

Foundation Medicine adds new immunotherapy features to its gene profiling products

August 23, 2016 Manufacturing and Production, Research and Development FoundationOne, oncology, tumour

Foundation Medicine hopes to enhance oncologist insight into potential immunotherapy responses with the addition of new clinical markers to its …
News
casebia

Bayer’s CRISPR venture opens for business in biotech hub

August 23, 2016 Manufacturing and Production, Research and Development Bayer, casebia, crispr, gene editing, gene-editing

Bayer and CRISPR Therapeutics have joined together to launch Casebia Therapeutics and have chosen Cambridge, Massachusetts, as its base to …
News
paul_herendeen

Valeant appoints new executive VP of finance and CFO

August 22, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Valeant, appointment

Valeant has announced the appointment of Paul S. Herendeen as executive vice president, who will also take over as chief …
Appointment
astrazeneca_logo_building

FDA fast tracks Alzheimer’s drug from Lilly, AstraZeneca

August 22, 2016 Manufacturing and Production, Research and Development Alzheimer's disease, AstraZeneca, BACE, lilly, phase III

AstraZeneca and Eli Lilly have announced that the US Food and Drug Administration (FDA) has granted AZD3293 its fast track …
News

Doctors receiving drugmaker payments more likely to prescribe their products, BMJ study finds

August 22, 2016 Research and Development, Sales and Marketing

US physicians who received gifts and other payments from drug companies were more likely to prescribe branded anticoagulants and diabetes …
News
sanofi_multaq

FDA delays appraisal of Sanofi, Zealand diabetes drug just days before decision due

August 22, 2016 Research and Development, Sales and Marketing NDA, Sanofi, appraisal, diabetes, iglarlixi, type 2, type-2, zealand

There was unfortunate news for Sanofi and Zealand Pharma as the FDA announced that it required additional information, constituting a …
News
clinical_trial_3

Intercept’s Ocaliva meets primary endpoint in Phase III trial for rare liver disease

August 18, 2016 Medical Communications, Research and Development intercept, ocaliva

Intercept Pharmaceuticals have announced the publication of Phase III results published in the New England Journal of Medicine, where Ocaliva …
News
The Gateway to Local Adoption Series

Latest content

Just – Evotec given Gates Foundation grant to increase global biotherapeutics access

January 8, 2026

Johnson & Johnson submits robotic surgical system for De Novo classification

January 8, 2026

EA Pharma announces phase 3 trial for new schizophrenia treatment in Japan

January 7, 2026

Eleva appoints Erich Rajkovic as Chief Business Officer

January 7, 2026

MedPharm announces US FDA inspection of North Carolina manufacturing facility

January 6, 2026